<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00107 Mid Day Module (Mixed Bag-4) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">40</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 55323,
    "choices": [
      {
        "id": 220753,
        "text": "<p><span style=\"font-size:12.0pt;\">Bronchogenic carcinoma</span></p>"
      },
      {
        "id": 220754,
        "text": "<p><span style=\"font-size:12.0pt;\">Aspergilloma</span></p>"
      },
      {
        "id": 220755,
        "text": "<p><span style=\"font-size:12.0pt;\">Lung abscess</span></p>"
      },
      {
        "id": 220756,
        "text": "<p><span style=\"font-size:12.0pt;\">Miliary TB</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with the X-ray. What is the most likely diagnosis? (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/29/screenshot-2024-08-29-180155.jpeg\" alt=\"\" width=\"300\" height=\"288\"></span></p>",
    "unique_key": "Q5531157",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877393,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Miliary TB</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Miliary tuberculosis (TB) is characterized by the presence of numerous small nodules that are uniformly distributed throughout the lungs. These nodules are millet-seed-sized, giving a \"miliary\" appearance on the chest X-ray. The image provided shows these numerous tiny nodules distributed evenly across both lung fields, which is classic for miliary TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Miliary TB occurs when a large number of Mycobacterium tuberculosis organisms disseminate through the bloodstream and lodge in multiple organs, most commonly the lungs. The small size and uniformity of the nodules in the X-ray are key diagnostic features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bronchogenic carcinoma:</strong> This typically presents as a mass lesion on an X-ray, which may cause collapse of the surrounding lung tissue. The absence of a clear mass lesion on the X-ray rules out bronchogenic carcinoma as the most likely diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aspergilloma:</strong> Aspergilloma is characterized by the presence of a <strong>fungal ball within a pre-existing lung cavity.</strong> On an X-ray, this would appear as a cavity with a round or oval density within it, often surrounded by an air crescent, known as the \"monad sign\" or \"air crescent sign.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/29/screenshot-2024-08-29-180316.jpeg\" alt=\"\" width=\"300\" height=\"318\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lung abscess:</strong> A lung abscess is typically seen as a cavity with an air-fluid level, where the top of the cavity shows air and the bottom contains fluid. The X-ray provided does not show such a cavity with an air-fluid level, making this option less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Miliary TB presents with numerous small, uniformly distributed nodules on a chest X-ray, resembling millet seeds. This pattern is a hallmark of disseminated tuberculosis.</span></p>",
    "correct_choice_id": 220756,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "FMGE",
      "ImageBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4278,
    "choices": [
      {
        "id": 17089,
        "text": "<p><span style=\"font-size:12.0pt;\">Albendazole is the drug of choice</span></p>"
      },
      {
        "id": 17090,
        "text": "<p><span style=\"font-size:12.0pt;\">Majority of infections are asymptomatic in humans</span></p>"
      },
      {
        "id": 17091,
        "text": "<p><span style=\"font-size:12.0pt;\">Infection is acquired by ingestion of aquatic plants</span></p>"
      },
      {
        "id": 17092,
        "text": "<p><span style=\"font-size:12.0pt;\">Non-segmented leaf like parasite</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding the given image is correct? (INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/untitled-303.jpg\" alt=\"\" width=\"250\" height=\"250\"></span></p>",
    "unique_key": "Q8233375",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877377,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Majority of infections are asymptomatic in humans</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows <strong>hymenolepis nana egg</strong>. Egg is spherical or ovoid and has a thin colorless outer membrane and inner embryophore enclosing the hexacanth oncosphere. The space between two membranes contains yolk granules and 4-8 thread like <strong>polar. Filaments</strong> arising from two knobs on the embryophore. The eggs float in saturated solution of salt and are non-bile stained. They are immediately infective and unable to survive for more than 10 days in external environment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hymenolepis nana is the smallest and the most common tapeworm found in the human intestine.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hymenolepiasis occurs more commonly in children. There are usually no symptoms but in heavy infections, there is nausea, anorexia, abdominal pain, diarrhea and irritability. Sometimes pruritus may occur due to an allergic response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Praziquantel</strong> (single dose of 25 mg/kg) is the drug of choice, since it acts both against the adult worms and the cysticercoids in the intestinal villi. Nitazoxanide 500 mg BD for 3 days may be used as alternative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Albendazole is the drug of choice</strong>: This is incorrect. The drug of choice for Hymenolepis nana is <strong>praziquantel</strong> (a single dose of 25 mg/kg) because it acts against both adult worms and the cysticercoids in the intestinal villi. Nitazoxanide (500 mg BD for 3 days) may be used as an alternative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Infection is acquired by ingestion of aquatic plants</strong>: This is incorrect. The infection with Hymenolepis nana is not acquired through aquatic plants. Infections are usually acquired by ingestion of contaminated food or water or by autoinfection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Non-segmented leaf-like parasite</strong>: This is incorrect. Hymenolepis nana is a segmented tapeworm, not a non-segmented leaf-like parasite.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hymenolepis nana&nbsp;</strong>(dwarf tapeworm) is the most common and smallest tapeworm in humans. Majority of infections are asymptomatic. The drug of choice is <strong>praziquantel</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parasites with aquatic plants as the source of infection:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Fasciola hepatica</span></li><li><span style=\"font-size:12.0pt;\">Fasciolopsis buski</span></li><li><span style=\"font-size:12.0pt;\">Watsonius watsoni</span></li><li><span style=\"font-size:12.0pt;\">Gastrodiscoides hominis</span></li></ul>",
    "correct_choice_id": 17090,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5698,
    "choices": [
      {
        "id": 22764,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testicular feminizing syndrome</span></span></span></span></p>"
      },
      {
        "id": 22765,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonadal dysgenesis</span></span></span></span></p>"
      },
      {
        "id": 22766,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kallmann syndrome</span></span></span></span></p>"
      },
      {
        "id": 22767,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Turner syndrome</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old girl with primary amenorrhea has the following features. What is the most probable diagnosis?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal stature</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thelarche - absent</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH, LH - high</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotype - 46 XX</span></span></span></span></li>\r\n</ul>",
    "unique_key": "Q1367573",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877380,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Gonadal dysgenesis </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The probable diagnosis in this case is pure gonadal dysgenesis. Primary amenorrhea with absent secondary sexual characteristics (thelarche) and high levels of FSH and LH indicate hypergonadotropic hypogonadism, which suggests an ovarian cause. The karyotype 46 XX confirms gonadal dysgenesis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Testicular feminizing syndrome/Androgen Insensitivity Syndrome</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition occurs in individuals with a 46 XY karyotype.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Individuals with this syndrome have absent uterus and ovaries and exhibit secondary sexual development, especially breast development, due to peripheral production of estrogens.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Kallmann Syndrome</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a cause of hypogonadotropic hypogonadism leading to primary amenorrhea.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is associated with anosmia and absent secondary sexual characteristics.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH and LH levels are low in this condition.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Turner Syndrome</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by a 45 XO karyotype.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Individuals have streak ovaries leading to low estrogen levels and absent secondary sexual characteristics.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH and LH levels are high.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A very important feature is short stature, which is not seen in the patient described.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary amenorrhea with high FSH and LH levels and a 46 XX karyotype indicates gonadal dysgenesis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 454, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 22765,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 51025,
    "choices": [
      {
        "id": 203633,
        "text": "<p><span style=\"font-size:12pt;\">Carina</span></p>"
      },
      {
        "id": 203634,
        "text": "<p><span style=\"font-size:12pt;\">Superior vena cava</span></p>"
      },
      {
        "id": 203635,
        "text": "<p><span style=\"font-size:12pt;\">Pulmonary trunk</span></p>"
      },
      {
        "id": 203636,
        "text": "<p><span style=\"font-size:12pt;\">Arch of Aorta</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the structure marked with an arrow: (</span>INICET Nov 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-101905.png\" alt=\"\" width=\"300\" height=\"263\"></span></p>",
    "unique_key": "Q8369513",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877385,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Pulmonary trunk</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given image represents a cross-sectional view of the thorax, and the structure marked by the arrow is identified as the pulmonary trunk. The key points to identify the pulmonary trunk are its location and the surrounding structures in the thoracic cross-section.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Pulmonary Trunk:</strong> The pulmonary trunk is a major vessel that arises from the right ventricle of the heart and bifurcates into the right and left pulmonary arteries. It is situated anterior to the aorta and is clearly visible in the image as a large tube dividing into two branches.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/4_vvBZy1I.jpg\" width=\"1142\" height=\"513\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Carina:</strong> The carina is the point at which the trachea bifurcates into the left and right main bronchi. It is located lower in the thoracic cavity and is not associated with the structures visible in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Superior vena cava:</strong> The superior vena cava is located to the right of the sternum and is not the structure marked by the arrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Arch of Aorta:</strong> The arch of the aorta is the curved portion of the aorta that gives rise to the brachiocephalic trunk, left common carotid artery, and left subclavian artery. In a cross-sectional view, it appears as an elongated structure, not as the large round structure marked by the arrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The pulmonary trunk is a major vessel located anterior to the aorta, bifurcating into the right and left pulmonary arteries, and is the structure identified by the arrow in the cross-sectional image of the thorax.</span></p>",
    "correct_choice_id": 203635,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5845,
    "choices": [
      {
        "id": 23350,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine artery embolization</span></span></span></p>"
      },
      {
        "id": 23351,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial ablation</span></span></span></p>"
      },
      {
        "id": 23352,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormonal therapy</span></span></span></p>"
      },
      {
        "id": 23353,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 33-year-old female patient comes with complaints of menorrhagia for the past 3 months. The duration and regularity of her menstrual cycles are normal. Non- hormonal management has been tried without success. What is the most appropriate next step?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (NEET PG 2020)</span></span></span></p>",
    "unique_key": "Q5599674",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877370,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Hormonal therapy </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormonal therapy is the next best management modality for menorrhagia when non-hormonal management has failed. This includes combined oral contraceptive pills or even progesterone-only devices like the LND-IUS.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First-line management includes non-hormonal treatment like NSAIDs and Tranexamic acid.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Uterine artery embolization</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Uterine artery embolization is a surgical option and is considered when other treatments fail.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Endometrial ablation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Endometrial ablation is also a surgical option and should be considered after hormonal therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hysterectomy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hysterectomy is the last resort and is used when all other management options fail or are contraindicated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormonal therapy, including combined oral contraceptive pills or progesterone-only devices like the LND-IUS, is the next best management step for menorrhagia when non-hormonal management has been ineffective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 197, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 23352,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5175,
    "choices": [
      {
        "id": 20673,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyper IgM syndrome</span></p>"
      },
      {
        "id": 20674,
        "text": "<p><span style=\"font-size:12.0pt;\">Wiskott-Aldrich syndrome</span></p>"
      },
      {
        "id": 20675,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyper IgE syndrome</span></p>"
      },
      {
        "id": 20676,
        "text": "<p><span style=\"font-size:12.0pt;\">Carcinoid syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An 11-year-old boy was brought to the pediatric OPD with multiple abscesses over his face, chest, and back. The child has a history of recurrent respiratory infections. On examination, he has atopic excoriating skin and multiple cold abscesses on his back. What is the most probable diagnosis? (NEET PG 2019)</span></p>",
    "unique_key": "Q8271789",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877364,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hyper IgE syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of the boy with recurrent skin and respiratory infections, atopic excoriating skin, and notably, cold abscesses, strongly points towards Hyper IgE syndrome, also known as Job's syndrome. This condition is characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>High levels of IgE:</strong> Elevated IgE is a hallmark of the syndrome and contributes to the immune dysregulation seen in these patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Recurrent infections:</strong> Due to defects in immune regulation, particularly affecting the response of neutrophils and other immune cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dermatologic issues:</strong> Such as eczema and atopic dermatitis are common and often severe in these patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Genetic background:</strong> Hyper IgE syndrome is commonly caused by mutations in the STAT3 gene, which is critical for many aspects of immune system function, including the development and function of neutrophils.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hyper IgM syndrome:</strong> Incorrect, characterized by elevated levels of IgM with low levels of other immunoglobulins, leading to a susceptibility to infections. It does not typically present with high IgE levels or eczema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Wiskott-Aldrich syndrome:</strong> Incorrect, this is a condition that affects blood cells and immune response, characterized by thrombocytopenia, eczema, and recurrent infections; however, it does not typically involve high levels of IgE or cold abscesses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Carcinoid syndrome:</strong> Incorrect, typically presents with symptoms caused by secreted hormones, such as flushing, diarrhea, and heart valve problems, which are unrelated to the immune dysfunction seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hyper IgE syndrome should be considered in patients presenting with a combination of high IgE levels, recurrent skin and respiratory infections, and dermatologic issues such as eczema. Managing this condition often involves addressing the skin care comprehensively and preventing infections through vigilant monitoring and appropriate use of antibiotics.</span></p>",
    "correct_choice_id": 20675,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16135,
    "choices": [
      {
        "id": 64500,
        "text": "<p><span style=\"font-size:12pt;\">Lymphedema</span></p>"
      },
      {
        "id": 64501,
        "text": "<p><span style=\"font-size:12pt;\">Arterial Disorders</span></p>"
      },
      {
        "id": 64502,
        "text": "<p><span style=\"font-size:12pt;\">Venous Disorders</span></p>"
      },
      {
        "id": 64503,
        "text": "<p><span style=\"font-size:12.0pt;\">Coronary heart disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 35-year-old male pt presented to your clinic with persistent non-pitting edema in their lower extremities as shown below. What could be the most likely reason for this symptom?&nbsp;(NEET PG 2020)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-153334.jpg\" alt=\"\" width=\"350\" height=\"422\"></p>",
    "unique_key": "Q4623278",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877401,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Lymphedema</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Lymphedema is the likeliest cause.</span></li><li><span style=\"font-size:12pt;\">It involves the build-up of protein-rich fluid in tissue interstitial spaces.</span></li><li><span style=\"font-size:12pt;\">It shows typical \u201cnon-pitting\u201d edema in the second stage of lymphedema.</span></li><li><span style=\"font-size:12pt;\">Filariasis is the most common etiology.</span></li><li><span style=\"font-size:12pt;\">In severe and long standing cases, skin changes are seen giving the limb an appearance of \u201cElephantiasis\u201d.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Arterial Disorders:</strong> Arterial disorders may lead to symptoms such as leg pain, intermittent claudication, and tissue damage due to reduced blood supply. Edema is uncommon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Venous Disorders:</strong> These disorders can encompass conditions like deep vein thrombosis (DVT), varicose veins, chronic venous insufficiency (CVI), and venous ulcers. Venous disorders may result in symptoms like leg swelling, pain, and skin changes, and they can vary in severity. No evidence of skin changes associated with varicose veins are seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Coronary Heart Disease:</strong> Coronary heart disease (CHD), also known as coronary artery disease (CAD), is a common heart condition where the coronary arteries that supply blood to the heart muscle become narrowed or blocked due to the buildup of fatty deposits (atherosclerosis). CAD may lead to heart failure leading to bilateral lower limb pitting edema, which is not seen in the case above.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Lymphedema is characterized by non-pitting edema due to the accumulation of protein-rich fluid in the tissue interstitial spaces. It can lead to significant swelling and skin changes, particularly in the lower extremities, distinguishing it from other causes of edema.</span></p>",
    "correct_choice_id": 64500,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24779,
    "choices": [
      {
        "id": 99077,
        "text": "<p><span style=\"font-size:12.0pt;\">1,2</span></p>"
      },
      {
        "id": 99078,
        "text": "<p><span style=\"font-size:12.0pt;\">3,4</span></p>"
      },
      {
        "id": 99079,
        "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4,5</span></p>"
      },
      {
        "id": 99080,
        "text": "<p><span style=\"font-size:12.0pt;\">2,3,4,5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are true about subclinical myocarditis? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Palpitations</span></li><li><span style=\"font-size:12.0pt;\">Elevated BNP Troponins</span></li><li><span style=\"font-size:12.0pt;\">Regional wall motion abnormalities in echo</span></li><li><span style=\"font-size:12.0pt;\">ECG suggestive of myocarditis</span></li><li><span style=\"font-size:12.0pt;\">Low LVEF in echo</span></li></ol>",
    "unique_key": "Q9009228",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877391,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2,3,4,5</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Subclinical myocarditis may not present with symptoms like palpitations, but can show:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. Elevated BNP/Troponins: Indicating myocardial injury.</span></p><p><span style=\"font-size:12.0pt;\">3. Regional wall motion abnormalities: Seen on echocardiography.</span></p><p><span style=\"font-size:12.0pt;\">4. ECG changes: Suggestive of myocarditis, such as non-specific ST-T changes.</span></p><p><span style=\"font-size:12.0pt;\">5. Low LVEF: Indicative of impaired left ventricular function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Palpitations are not a feature of subclinical myocarditis.</span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subclinical myocarditis can present with elevated cardiac biomarkers, regional wall motion abnormalities, ECG changes, and reduced LVEF, but not Palpitations, which is common in viral myocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Past common causes of myocarditis: Coxsackie virus types A and B.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Currently, Most common cause of myocarditis: Parvovirus B19 and HHV6.</span></p>",
    "correct_choice_id": 99080,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11354,
    "choices": [
      {
        "id": 45382,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sarcoidosis</span></span></span></p>"
      },
      {
        "id": 45383,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
      },
      {
        "id": 45384,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lymphoma</span></span></span></p>"
      },
      {
        "id": 45385,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypersensitive pneumonitis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents to you with fever, night sweats, ptosis, and bilateral facial nerve palsy. Investigations showed leukocytosis and bilateral hilar lymphadenopathy. Which of the following is the most likely diagnosis? (Neet pg 2022)</span></span></span></p>",
    "unique_key": "Q4214208",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877374,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Sarcoidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with fever, night sweats, ptosis, and bilateral facial nerve palsy. The investigations show leukocytosis and bilateral hilar lymphadenopathy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hilar lymphadenopathy can be seen in many conditions like Sarcoidosis, Pneumoconiosis, TB, etc</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">But the other clinical features point towards sarcoidosis, a systemic inflammatory disease characterized by non-caseating granulomas. Sarcoidosis can affect multiple organs, but it commonly involves the lungs and lymph nodes. Bilateral hilar lymphadenopathy is a hallmark finding in sarcoidosis and is often the first clue in diagnosis. Additionally, sarcoidosis can present with systemic symptoms like fever and night sweats.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of bilateral facial nerve palsy is another significant clue. While Guillain-Barre syndrome, Lyme disease, and sarcoidosis can cause bilateral lower motor neuron (LMN) type facial palsy, the combination of other symptoms and bilateral hilar lymphadenopathy strongly favors sarcoidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Tuberculosis: </span></strong><span style=\"font-size:12.0pt\">Tuberculosis (TB) can present with fever, night sweats, and lymphadenopathy, including hilar lymphadenopathy. However, TB typically causes caseating granulomas and does not commonly present with bilateral facial nerve palsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Lymphoma</strong>: Lymphoma can also present with fever, night sweats, and lymphadenopathy. However, it typically involves systemic B symptoms and other lymph node groups. Bilateral facial nerve palsy is not a common presentation of lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Hypersensitive pneumonitis</span></strong><span style=\"font-size:12.0pt\">: Hypersensitive pneumonitis can present with respiratory symptoms and lymphadenopathy, but it is usually associated with exposure to inhaled organic antigens. It does not typically cause systemic symptoms like fever, night sweats, and bilateral facial nerve palsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral hilar lymphadenopathy with systemic symptoms like fever and night sweats and the presence of bilateral facial nerve palsy is highly suggestive of sarcoidosis. Always consider sarcoidosis first in such clinical scenarios.</span></span></p>",
    "correct_choice_id": 45382,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 43257,
    "choices": [
      {
        "id": 172695,
        "text": "<p><span style=\"font-size:12pt;\">Mild illness</span></p>"
      },
      {
        "id": 172696,
        "text": "<p><span style=\"font-size:12pt;\">&nbsp;Moderate illness</span></p>"
      },
      {
        "id": 172697,
        "text": "<p><span style=\"font-size:12pt;\">&nbsp;Severe illness which is&nbsp; constant threat to life</span></p>"
      },
      {
        "id": 172698,
        "text": "<p><span style=\"font-size:12.0pt;\">Severe illness</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following criteria corresponding to ASA grade III?&nbsp;</span>(INICET NOVEMBER 2023)</p>",
    "unique_key": "Q3781122",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877372,
    "difficulty_level": "intermediate",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D.&nbsp;Severe illness</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><strong>Option&nbsp;</strong><span style=\"font-size:12pt;\"><strong>D. Severe illness:</strong> The American Society of Anesthesiologists (ASA) Physical Status Classification System is used to assess and communicate a patient's pre-anesthesia medical co-morbidities. ASA grade III is defined as a patient with severe systemic disease that is not incapacitating. This means the patient has a serious illness, but it does not necessarily pose a constant threat to life, which would correspond to ASA IV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">&nbsp;<strong>Option&nbsp;A. Mild illness</strong>: This corresponds to ASA II, which is defined as a patient with mild systemic disease. It does not reach the severity required for ASA III.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B. Moderate illness</strong>: This is not an official ASA classification term. The closest would be ASA II (mild systemic disease) or ASA III (severe systemic disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C. Severe illness which is a constant threat to life: </strong>This corresponds to ASA IV. It describes a patient with severe systemic disease that poses a constant threat to life, not ASA III.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">ASA grade III corresponds to a patient with severe systemic disease that is not incapacitating.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>The classification system is as follows:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>ASA I</strong>: A normal healthy patient.</span></li><li><span style=\"font-size:12pt;\"><strong>ASA II</strong>: A patient with mild systemic disease.</span></li><li><span style=\"font-size:12pt;\"><strong>ASA III</strong>: A patient with severe systemic disease that is not incapacitating.</span></li><li><span style=\"font-size:12pt;\"><strong>ASA IV</strong>: A patient with severe systemic disease that is a constant threat to life.</span></li><li><span style=\"font-size:12pt;\"><strong>ASA V</strong>: A moribund patient who is not expected to survive without the operation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>ASA VI</strong>: A declared brain-dead patient whose organs are being removed for donor purposes.</span></li></ol>",
    "correct_choice_id": 172698,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 21821,
    "choices": [
      {
        "id": 87248,
        "text": "<p><span style=\"font-size:12pt;\">Malpresentation of fetus</span></p>"
      },
      {
        "id": 87249,
        "text": "<p><span style=\"font-size:12pt;\">Heart disease in mother</span></p>"
      },
      {
        "id": 87250,
        "text": "<p><span style=\"font-size:12pt;\">Premature labour</span></p>"
      },
      {
        "id": 87251,
        "text": "<p><span style=\"font-size:12pt;\">Hypothyroidism</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a contraindication to given drug?&nbsp;</span>(FMGE JAN 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1053.jpg\" alt=\"\" width=\"200\" height=\"338\"></span></p>",
    "unique_key": "Q6453830",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877368,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Malpresentation of fetus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given drug in the image is Oxytocin, which is commonly used to induce or augment labor. However, its use is contraindicated in several conditions to avoid complications during childbirth. One such contraindication is malpresentation of the fetus, where the fetus is not in a head-down position, potentially complicating a vaginal delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Contraindications to Oxytocin:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Grand multipara:</strong> Women who have given birth five or more times.</span></li><li><span style=\"font-size:12pt;\"><strong>Contracted pelvis:</strong> A pelvis that is too small to allow the passage of the fetus.</span></li><li><span style=\"font-size:12pt;\"><strong>History of Classical Cesarean Section:</strong> Classical C-sections involve a vertical incision in the uterus, increasing the risk of uterine rupture.</span></li><li><span style=\"font-size:12pt;\"><strong>History of 2 or more Lower Segment Cesarean Sections (LSCS):</strong> Multiple C-sections also increase the risk of uterine rupture.</span></li><li><span style=\"font-size:12pt;\"><strong>Malpresentation:</strong> Includes breech, transverse, or any non-cephalic presentation of the fetus.</span></li><li><span style=\"font-size:12pt;\"><strong>Obstructed labor:</strong> Labor that does not progress due to physical obstruction.</span></li><li><span style=\"font-size:12pt;\"><strong>Fetal distress:</strong> Signs that the fetus is not well, such as abnormal heart rate patterns.</span></li><li><span style=\"font-size:12pt;\"><strong>Hypovolemia:</strong> Reduced blood volume in the mother, which can complicate the use of oxytocin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Heart disease in mother</strong>:<strong> </strong>Heart disease in the mother is considered a relative contraindication for oxytocin administration. It requires careful monitoring and assessment by the healthcare provider, but it is not an absolute contraindication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Premature labour</strong>:<strong> </strong>Oxytocin can sometimes be used to manage labor in preterm situations under strict medical supervision. It is not an absolute contraindication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hypothyroidism</strong>: Hypothyroidism is not a contraindication for the use of oxytocin. Proper management of hypothyroidism is necessary during pregnancy, but it does not specifically preclude the use of oxytocin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Oxytocin is contraindicated in malpresentation of the fetus, grand multipara, contracted pelvis, history of classical cesarean, history of 2 or more LSCS, obstructed labor, fetal distress, and hypovolemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 573, DC Dutta\u2019s Textbook of Obstetrics 226<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 87248,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14123,
    "choices": [
      {
        "id": 56453,
        "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-2, D-1</span></p>"
      },
      {
        "id": 56454,
        "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-1, C-2, D-4</span></p>"
      },
      {
        "id": 56455,
        "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-4, C-3, D-1</span></p>"
      },
      {
        "id": 56456,
        "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-1, C-2, D-3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the following: (AIIMS NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-144711.png\" alt=\"\" width=\"600\" height=\"619\"></span></p><p>&nbsp;</p><p>&nbsp;</p>",
    "unique_key": "Q9621059",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877395,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) A-4, B-1, C-2, D-3</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Uro bags - collection of urine.</span></li><li><span style=\"font-size:12.0pt;\">An underwater seal bag- collection of drainage fluid from the thoracic cavity.</span></li><li><span style=\"font-size:12.0pt;\">Nasogastric tube / Ryle's tube - Used for Nasogastric feeding / Stomach wash / Aspiration</span></li><li><span style=\"font-size:12.0pt;\">Metallic suction cannula - To clear the operative field by suctioning secretions/blood</span></li></ul>",
    "correct_choice_id": 56456,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6524,
    "choices": [
      {
        "id": 26065,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin E</span></p>"
      },
      {
        "id": 26066,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
      },
      {
        "id": 26067,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
      },
      {
        "id": 26068,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A young patient began taking a weight loss medication that works by preventing fat absorption from food. She developed easy bruising and increased menstrual bleeding after a few weeks. Which of the following vitamins deficiency is likely to be responsible for her condition? (NEET PG 2022)</span></p>",
    "unique_key": "Q7651343",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877392,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin K</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vitamin A, D, E and K are fat soluble vitamins. Their absorption is hampered when the absorption of fat is prevented by a medication (eg Orlistat , Ezetimibe etc).</span></li><li><span style=\"font-size:12.0pt;\">Vitamin K is required for the Gamma carboxylation of Glutamic acid residues of clotting factors 2 ,7 ,9 and 10 in order to activate them. If Vitamin K is deficient due to fat malabsorption, as in the above case, then there can be bleeding manifestations in the form of easy bruising and increased menstrual bleeding in females. The Prothrombin Time (PT) will be elevated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vitamin E:&nbsp;</strong>Vitamin E deficiency can manifest as hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B6:&nbsp;</strong>Vitamin B6 deficiency can be seen with drugs like Isoniazid, Penicillamine, Hydralazine, OCP. Patients can have peripheral neuritis, lowered seizure threshold, or convulsions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin D:</strong> Vitamin D deficiency leads to the development of rickets in children and osteomalacia in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin K deficiency due to impaired fat absorption from weight loss medications can lead to bleeding manifestations such as easy bruising and increased menstrual bleeding.</span></p>",
    "correct_choice_id": 26066,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 2082,
    "choices": [
      {
        "id": 8321,
        "text": "<p><span style=\"font-size:12.0pt;\">G</span></p>"
      },
      {
        "id": 8322,
        "text": "<p><span style=\"font-size:12.0pt;\">NOR</span></p>"
      },
      {
        "id": 8323,
        "text": "<p><span style=\"font-size:12.0pt;\">C</span></p>"
      },
      {
        "id": 8324,
        "text": "<p><span style=\"font-size:12.0pt;\">R</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Banding technique used for dicentric chromosomes:</span>(INICET MAY 2022)</p>",
    "unique_key": "Q7003614",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877366,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dicentric chromosome is an abnormal chromosome with two centromeres.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture1_uAopcR9.jpg\" alt=\"\" width=\"300\" height=\"196\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>C banding</strong>: stains heterochromatin which are regions of the chromosomes at or near centromere. <strong>So, C banding will be most useful for dicentric chromosomes.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. G-banding:</strong> G-banding is the most common banding technique and uses Giemsa stain to stain AT-rich regions. It was developed as an alternative to Q-banding due to the cumbersome nature of Q-banding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NOR-banding:</strong> NOR-banding (Nucleolar Organizer Region) is used to stain regions associated with nucleolus formation and is not specifically useful for dicentric chromosomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. R-banding:</strong> R-banding provides a reverse pattern to G-banding, staining GC-rich regions instead of AT-rich regions. It is not specifically useful for identifying dicentric chromosomes.</span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Note \u2013&nbsp; Q banding</strong>: uses quinacrine dye (first used dye) and stains repetitive AT rich regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C-banding is the preferred technique for identifying dicentric chromosomes as it specifically stains heterochromatin regions at or near the centromere.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Robbins 10th Ed. / page- 262-263, 293</strong></span></p>",
    "correct_choice_id": 8323,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11262,
    "choices": [
      {
        "id": 45014,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restrictive disease</span></span></p>"
      },
      {
        "id": 45015,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive disease</span></span></p>"
      },
      {
        "id": 45016,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal lung function</span></span></p>"
      },
      {
        "id": 45017,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interstitial lung disease</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On performing a pulmonary function test, reduction in FEV1/FVC is characteristic of: (NEET PG 2019)</span></span></p>",
    "unique_key": "Q3575475",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877371,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Obstructive disease</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A reduction in the FEV1/FVC ratio (Forced Expiratory Volume in 1 second / Forced Vital Capacity) is characteristic of obstructive lung diseases. This ratio is a key indicator used to differentiate between obstructive and restrictive lung patterns on pulmonary function tests. In obstructive diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis, there is a disproportionate reduction in FEV1 relative to FVC due to airflow limitation and air trapping.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/screenshot-2024-10-03-094610.png\" style=\"height:211px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Restrictive disease:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In restrictive lung diseases, both FEV1 and FVC are reduced proportionally, often leading to a normal or even increased FEV1/FVC ratio. Restrictive diseases include conditions such as pulmonary fibrosis and other interstitial lung diseases.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Normal lung function:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal lung function would typically show an FEV1/FVC ratio within the normal range, which is generally above 0.7 in healthy adults.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Interstitial lung disease:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is a type of restrictive lung disease where there is a reduction in lung volumes, but the FEV1/FVC ratio is typically normal or increased, not reduced.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1/FVC reduction implies obstruction. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1/FVC Increased or normal &ndash; <strong>Restrictive lung disease</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in Maximum Mid-expiratory flow (MMEF) i.e., FEV25%-75% - <strong>Small airway disease</strong></span></span></span></span></li>\r\n</ul>",
    "correct_choice_id": 45015,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57443,
    "choices": [
      {
        "id": 229145,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine antagonism</span></span></p>"
      },
      {
        "id": 229146,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased discharge of norepinephrine from the locus ceruleus</span></span></p>"
      },
      {
        "id": 229147,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Release of histamine</span></span></p>"
      },
      {
        "id": 229148,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of phosphodiesterase</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caffeine is a widely used stimulant that promotes wakefulness. Which of the following mechanisms is responsible for this effect? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q2699678",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877397,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Adenosine antagonism</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caffeine exerts its stimulant effects primarily through the antagonism of adenosine receptors, specifically the A1 receptors in the brain. Adenosine is a neuromodulator that generally promotes sleep and relaxation by inhibiting neuronal activity. By blocking adenosine&#39;s action, caffeine prevents this inhibitory effect, leading to increased alertness and wakefulness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caffeine&rsquo;s ability to keep you awake and alert is also related to its secondary effects, including the release of norepinephrine from the locus ceruleus and inhibition of phosphodiesterase, which increases cyclic AMP levels. However, the primary mechanism responsible for promoting wakefulness is the antagonism of adenosine receptors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember - Side effects of ADEnosine antagonism:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> for Arrhythmias</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> for Diuresis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> for Epileptic seizures.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased discharge of norepinephrine from the locus ceruleus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While caffeine can increase the release of norepinephrine, which is involved in alertness and arousal, this is not the primary mechanism for its wakefulness-promoting effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Release of histamine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Histamine release is associated with wakefulness, but this is not a direct mechanism of action for caffeine. Histamine release is more associated with other pathways in the brain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Inhibition of phosphodiesterase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Caffeine does inhibit phosphodiesterase, leading to increased levels of cyclic AMP, but this mechanism is more relevant to its cardiovascular and smooth muscle effects rather than its role in promoting wakefulness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caffeine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a widely used stimulant that promotes wakefulness through three main mechanisms:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits phosphodiesterase enzyme.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acts as an adenosine A1 receptor antagonist.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Releases norepinephrine from the locus coeruleus.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caffeine promotes wakefulness primarily through the antagonism of adenosine receptors, blocking the sleep-inducing effects of adenosine and resulting in increased alertness</span></span></span></p>",
    "correct_choice_id": 229145,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 21809,
    "choices": [
      {
        "id": 87200,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stria Gravidarum</span></span></span></p>"
      },
      {
        "id": 87201,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linea Alba</span></span></span></p>"
      },
      {
        "id": 87202,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linea Nigra</span></span></span></p>"
      },
      {
        "id": 87203,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stria albicans</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the finding shown in image given below:&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">(FMGE JANUARY 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1046_Xio1rZb.jpg\" style=\"height:265px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q9228057",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877387,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Linea Nigra</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A hyperpigmented line from xiphisternum to pubic symphysis is Linea Nigra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><strong><span style=\"font-family:Calibri,sans-serif\">Option A.</span><span style=\"font-family:Times New Roman, serif\">&nbsp;</span></strong><strong style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stria gravidarum</span></strong><span style=\"font-family:Calibri,sans-serif\">: Stria gravidarum is a reddish stria of present pregnancy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Linea Alba</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The midline of the anterior abdominal wall skin. It takes on dark brown-black pigmentation to form the linea nigra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><strong><span style=\"font-family:Calibri,sans-serif\">&nbsp;Option D.</span><span style=\"font-family:Times New Roman, serif\">&nbsp;</span></strong><strong style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stria albicans</span></strong><span style=\"font-family:Calibri,sans-serif\">: Stria albicans is a silvery stria of previous pregnancies.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A hyperpigmented line from xiphisternum to pubic symphysis is Linea Nigra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 79, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 87202,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4172,
    "choices": [
      {
        "id": 16667,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">E1, E2, E5</span></span></span></p>"
      },
      {
        "id": 16668,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">E6, E7</span></span></span></p>"
      },
      {
        "id": 16669,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">L1, L2</span></span></span></p>"
      },
      {
        "id": 16670,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E1, E2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image below shows the life cycle of a virus. Which of the proteins of the virus act as oncogenes? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-83.jpg\" style=\"height:459px; width:400px\" /></span></span></span></p>",
    "unique_key": "Q7649895",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877367,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) E6, E7</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The image shows the life cycle of the human papilloma virus, and the E6 and E7 proteins act as oncogenes</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-84.jpg\" style=\"height:556px; width:728px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV oncogenes <strong>E6 and E7 deregulate host cell cycle by binding and inactivating tumor suppressor genes p53 and pRb</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Binding of E6 gene to p53 causes degradation of p53. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E7 gene binds to pRb and disrupts the complex between pRb and E2F leading to uncontrolled proliferation. HPV, human papilloma virus.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-85.jpg\" style=\"height:486px; width:783px\" /></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E6 and E7 proteins of HPV are the primary oncogenes responsible for the virus&#39;s ability to cause cancer. They do this by inactivating key tumor suppressor proteins, p53 and pRb, leading to uncontrolled cell growth and proliferation.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 16668,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47652,
    "choices": [
      {
        "id": 190219,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBS</span></span></span></span></p>"
      },
      {
        "id": 190220,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FBS</span></span></span></span></p>"
      },
      {
        "id": 190221,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PPBS</span></span></span></span></p>"
      },
      {
        "id": 190222,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbA1C</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A wife is complaining that her husband is not taking medications for his diabetes regularly and not maintaining his blood glucose for a long time. Which of the following markers is best for long-duration glucose analysis? (</span></span>FMGE Jan 2024</p>",
    "unique_key": "Q4406789",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877399,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) HbA1C</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbA1c, or glycated hemoglobin, is the best marker for assessing long-term glucose control in diabetic patients. It reflects the average blood glucose levels over the past two to three months. This is because glucose binds to hemoglobin in red blood cells, and since red blood cells have a lifespan of about 120 days, the HbA1c value provides a long-term overview of blood glucose levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. RBS</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Not suitable for long-term glucose control as it only measures blood sugar at a specific moment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. FBS</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Provides fasting glucose levels but does not give a long-term picture.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. PPBS</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Useful for assessing post-meal glucose control but not for long-term analysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbA1c is the best marker for long-term glucose analysis in diabetic patients as it reflects average blood glucose levels over the past two to three months.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The target HbA1c for most patients with diabetes to ensure adequate control is less than 7%, though this may vary based on individual patient circumstances.</span></span></span></span></p>",
    "correct_choice_id": 190222,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 58407,
    "choices": [
      {
        "id": 232965,
        "text": "<p><span style=\"font-size:12.0pt;\">EWSR1, WT1</span></p>"
      },
      {
        "id": 232966,
        "text": "<p><span style=\"font-size:12.0pt;\">T11, 22</span></p>"
      },
      {
        "id": 232967,
        "text": "<p><span style=\"font-size:12.0pt;\">T15, 17</span></p>"
      },
      {
        "id": 232968,
        "text": "<p><span style=\"font-size:12.0pt;\">T2, 13</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which type of translocation is seen in diaphyseal tumor with small blue round cells? (NEET PG 2024)</span></p>",
    "unique_key": "Q6185015",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877402,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) T11, 22</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The question refers to <strong>Ewing's sarcoma</strong>, a type of malignant tumor that typically affects the diaphysis (shaft) of long bones, particularly in children and young adults. The tumor is characterized by small, round, blue cells when viewed under a microscope. A hallmark of Ewing's sarcoma is the <strong>t(11;22) translocation</strong>, which fuses the <strong>EWSR1 gene</strong> on chromosome 22 with the <strong>FLI1 gene</strong> on chromosome 11. This translocation results in the production of an abnormal protein that drives the cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This translocation, <strong>t(11;22)</strong>, is highly specific for Ewing's sarcoma and is used as a diagnostic marker.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mic 2 (CD99) \u2013 Most specific marker for Ewing\u2019s sarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. EWSR1, WT1: </strong>This combination is incorrect for Ewing's sarcoma. While EWSR1 is involved, WT1 is a gene associated with Wilms' tumor, a kidney cancer, and is not involved in Ewing's sarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. T15,17: </strong>This translocation is characteristic of acute promyelocytic leukemia (APL), not Ewing's sarcoma. The fusion of the PML and RARA genes occurs in APL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. T2,13: </strong>This translocation is associated with alveolar rhabdomyosarcoma, another type of soft tissue tumor, but not with Ewing's sarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>t(11;22) translocation</strong> is characteristic of <strong>Ewing's sarcoma</strong>, a diaphyseal tumor with small, round, blue cells, making it a crucial genetic marker for diagnosis.</span></p>",
    "correct_choice_id": 232966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54945,
    "choices": [
      {
        "id": 219241,
        "text": "<p><span style=\"font-size:12.0pt;\">AB</span></p>"
      },
      {
        "id": 219242,
        "text": "<p><span style=\"font-size:12.0pt;\">O positive</span></p>"
      },
      {
        "id": 219243,
        "text": "<p><span style=\"font-size:12.0pt;\">Oh</span></p>"
      },
      {
        "id": 219244,
        "text": "<p><span style=\"font-size:12.0pt;\">O negative</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What blood group should be given to a patient with Bombay blood group? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q8239844",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877398,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C) Oh</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Bombay blood group, also known as the Oh phenotype, is one of the <strong>rarest blood groups</strong> in the world. It was discovered in 1952 by Dr Y.M. Bhende.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Individuals with this blood group lack the H antigen, which is a precursor to the A and B antigens found on the red blood cells of most individuals. The absence of the H antigen means that even blood type O, which normally has the H antigen, is not compatible with individuals who have the Bombay phenotype.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">People with the Bombay blood group produce anti-H antibodies in addition to anti-A and anti-B antibodies. This means that they cannot receive blood from any of the common blood types (A, B, AB, or O), as all of these contain the H antigen and would lead to a severe transfusion reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The only blood that can be safely transfused into a person with the Bombay blood group is blood from another Bombay blood group donor, which is denoted as Oh.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/27/5_62287365066771709312.jpg\" alt=\"\" width=\"700\" height=\"447\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. AB:</strong> Individuals with blood group AB have both A and B antigens. This blood group would not be compatible with a Bombay blood group recipient, as it would cause a severe transfusion reaction due to the presence of H antigen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. O positive:</strong> Blood group O positive still has the H antigen, even though it lacks A and B antigens. Transfusing O positive blood into a Bombay blood group individual would also lead to a transfusion reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. O negative:</strong> Like O positive, O negative blood has the H antigen and would not be suitable for a Bombay blood group recipient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Bombay blood group (Oh phenotype) is extremely rare, and individuals with this blood type can only receive blood from another Bombay blood group donor due to the absence of the H antigen and the presence of anti-H antibodies.</span></p>",
    "correct_choice_id": 219243,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57636,
    "choices": [
      {
        "id": 229913,
        "text": "<p><span style=\"font-size:12.0pt;\">BCR-ABL</span></p>"
      },
      {
        "id": 229914,
        "text": "<p><span style=\"font-size:12.0pt;\">NPM</span></p>"
      },
      {
        "id": 229915,
        "text": "<p><span style=\"font-size:12.0pt;\">PML-RARA</span></p>"
      },
      {
        "id": 229916,
        "text": "<p><span style=\"font-size:12.0pt;\">Inv 16</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An elderly patient underwent investigations which revealed Hb 9 g/dL, TLC 50,000/mm\u00b3, \u2191PT, \u2191aPTT, low platelet count, and increased D-dimers. Which of the following is the likely gene affected in the patient? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf14.jpg\" alt=\"\" width=\"400\" height=\"291\"></span></p>",
    "unique_key": "Q8412502",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877381,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) PML- RARA</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The patient's presentation with anemia, elevated white blood cell count, prolonged PT and aPTT, low platelet count, and increased D-dimers is indicative of disseminated intravascular coagulation (DIC).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DIC is commonly associated with Acute Promyelocytic Leukemia (APL), previously known as AML M3. APL is characterized by a translocation between chromosomes 15 and 17, resulting in the PML-RARA fusion gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This fusion disrupts the normal function of the retinoic acid receptor, blocking the differentiation of promyelocytes and leading to an accumulation of immature cells. APL is strongly associated with DIC due to the procoagulant activity of the promyelocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. BCR-ABL:</strong> BCR-ABL is a fusion gene associated with chronic myeloid leukemia (CML), resulting from the Philadelphia chromosome translocation (t(9;22)). It leads to unregulated tyrosine kinase activity, promoting proliferation of myeloid cells. It is not typically associated with DIC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NPM:</strong> Nucleophosmin (NPM) mutations are associated with a subset of Acute Myeloid Leukemia (AML) without recurrent cytogenetic abnormalities, often presenting with a normal karyotype. It does not typically present with the coagulation abnormalities seen in DIC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inv 16:</strong> Inv(16) is associated with a specific subtype of AML (AML M4Eo), which involves abnormal eosinophils and monocytic cells. While it is an important genetic alteration in AML, it is not specifically linked with the coagulation issues seen in APL and DIC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">APL (acute promyelocytic leukemia) is characterized by the PML-RARA fusion gene and is highly associated with DIC, which can be identified by a combination of bleeding tendencies and abnormal coagulation profiles.</span></p>",
    "correct_choice_id": 229915,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24739,
    "choices": [
      {
        "id": 98917,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stagnant hypoxia</span></span></span></p>"
      },
      {
        "id": 98918,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histotoxic hypoxia</span></span></span></p>"
      },
      {
        "id": 98919,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoxic hypoxia</span></span></span></p>"
      },
      {
        "id": 98920,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemic hypoxia</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the type of hypoxia according to given graph: (Brown graph is normal)</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-125697.jpg\" style=\"height:335px; width:400px\" /></span></span></p>",
    "unique_key": "Q4485811",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877389,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Anemic hypoxia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given graph illustrates a 50% reduction in the oxygen saturation of hemoglobin, even though the partial pressure of oxygen (PO2) stays within the expected range. This state is termed anemic hypoxia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anemic hypoxia occurs when there is a reduction in the oxygen-carrying capacity of the blood, usually due to a lower amount of hemoglobin, as seen in anemia. Despite normal levels of PO2, the overall oxygen content in the blood is diminished, leading to insufficient oxygen delivery to tissues.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Stagnant hypoxia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This occurs when oxygen deficiency is due to poor blood circulation, not a reduced oxygen-carrying capacity of the blood. It is caused by issues like arterial obstruction or ischemia. The graph for stagnant hypoxia would show normal oxygen content in arterial blood but lower content in venous blood due to poor perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Histotoxic hypoxia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In this type, the cells are unable to utilize oxygen effectively, even though it is adequately supplied by the blood. This condition is typically caused by toxins like cyanide that impair cellular respiration. The graph for histotoxic hypoxia would show normal oxygen content in both arterial and venous blood since the issue is within the cells&#39; ability to use oxygen, not the blood&#39;s ability to transport it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Hypoxic hypoxia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This occurs when there is a generalized lack of oxygen in the body&#39;s tissues due to low oxygen in the blood, often seen at high altitudes or in conditions like COPD. The graph would show reduced PO2 along with decreased oxygen content in both arterial and venous blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stagnant hypoxia: Oxygen deficiency due to poor blood circulation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histotoxic hypoxia: Cells unable to utilize oxygen despite its availability.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoxic hypoxia: Generalized lack of oxygen in the body&#39;s tissues.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemic hypoxia: Reduced oxygen-carrying capacity of blood due to low hemoglobin.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-125698.jpg\" style=\"height:200px; width:700px\" /></span></span></span></p>",
    "correct_choice_id": 98920,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 46008,
    "choices": [
      {
        "id": 183655,
        "text": "<p><span style=\"font-size:12.0pt;\">Ryanodine receptor</span></p>"
      },
      {
        "id": 183656,
        "text": "<p><span style=\"font-size:12.0pt;\">Dihydropyridine receptor</span></p>"
      },
      {
        "id": 183657,
        "text": "<p><span style=\"font-size:12.0pt;\">SERCA</span></p>"
      },
      {
        "id": 183658,
        "text": "<p><span style=\"font-size:12.0pt;\">Nicotinic receptor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Voltage-gated calcium channel present on T-tubule is:&nbsp;</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q6878018",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877369,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Dihydropyridine receptor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The T-tubules, or transverse tubules, are invaginations of the <strong>sarcolemma (muscle cell membrane)</strong> that play a crucial role in transmitting action potentials from the sarcolemma to the interior of the muscle fiber.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The voltage-gated calcium channels present on the T-tubules are known as <strong>dihydropyridine receptors (DHPR).</strong> These receptors are critical for the excitation-contraction coupling in muscle cells.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Dihydropyridine receptor</strong>: These receptors are voltage-gated calcium channels located on the T-tubules. When an action potential travels down the T-tubule, it activates the DHPR, which in turn mechanically activates the ryanodine receptor (RYR) on the sarcoplasmic reticulum, leading to the release of calcium ions into the cytoplasm and triggering muscle contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ryanodine receptor</strong>: This receptor is also involved in calcium release but is located on the sarcoplasmic reticulum, not on the T-tubules. It is mechanically coupled to the DHPR in skeletal muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. SERCA</strong>: The Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA) pump is responsible for pumping calcium back into the sarcoplasmic reticulum, but it is not located on the T-tubules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nicotinic receptor</strong>: These are ligand-gated cation channels located at the neuromuscular junction on the sarcolemma, not on the T-tubules. They are responsible for initiating the action potential in response to acetylcholine but are not involved in calcium transport in the T-tubules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The voltage-gated calcium channel present on the T-tubules is the dihydropyridine receptor (DHPR), which plays a crucial role in the excitation-contraction coupling in muscle cells.</span></p>",
    "correct_choice_id": 183656,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20254,
    "choices": [
      {
        "id": 80977,
        "text": "<p><span style=\"font-size:12.0pt;\">Parkinson\u2019s Disease</span></p>"
      },
      {
        "id": 80978,
        "text": "<p><span style=\"font-size:12.0pt;\">Prion\u2019s Disease</span></p>"
      },
      {
        "id": 80979,
        "text": "<p><span style=\"font-size:12.0pt;\">Huntington\u2019s Disease</span></p>"
      },
      {
        "id": 80980,
        "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer\u2019s Disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An 80-year-old woman presents with a progressive decline in daily activity. She gives a history of staring into space with frequent visual hallucinations. Pathology reveals Lewy bodies in neurons. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
    "unique_key": "Q8942357",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877396,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Parkinson\u2019s Disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence <strong>of Lewy bodies,</strong> which are <strong>aggregates of alpha-synuclein protein</strong>, in neurons suggests either Parkinson's disease or Lewy body dementia. Given the patient's symptoms of progressive decline in daily activity, visual hallucinations, and pathology findings, Parkinson's disease is the most likely diagnosis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Lewy Bodies:</strong> These are characteristic of Parkinson\u2019s disease and Lewy body dementia. They are intraneuronal inclusions primarily composed of alpha-synuclein.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Visual Hallucinations:</strong> These are more common in Parkinson's disease and Lewy body dementia compared to other neurodegenerative disorders.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Parkinson\u2019s Disease:</strong> The diagnosis is supported by the clinical history of visual hallucinations and progressive decline, alongside the pathological finding of Lewy bodies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Prion\u2019s Disease:</strong> Typically presents with rapidly progressing dementia and myoclonus. EEG shows characteristic periodic sharp wave complexes, and CSF may show elevated 14.3.3 protein. This does not match the patient's clinical picture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Huntington\u2019s Disease</strong>: An inherited condition characterized by the classic triad of dementia, chorea, and psychiatric manifestations. This condition usually presents earlier in life and has a strong family history component.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alzheimer\u2019s Disease:</strong> Primarily presents with memory loss and later with visual-spatial problems and the \"four A\u2019s\" (amnesia, agnosia, apraxia, aphasia). Pathologically, it is characterized by beta-amyloid plaques and tau protein tangles, not Lewy bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Lewy bodies in neurons and clinical features such as visual hallucinations and progressive decline in activity are indicative of Parkinson\u2019s disease.</span></p>",
    "correct_choice_id": 80977,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16116,
    "choices": [
      {
        "id": 64424,
        "text": "<p><span style=\"font-size:12.0pt;\">During feeding</span></p>"
      },
      {
        "id": 64425,
        "text": "<p><span style=\"font-size:12.0pt;\">Soon after birth</span></p>"
      },
      {
        "id": 64426,
        "text": "<p><span style=\"font-size:12.0pt;\">During palpation, over the left hypochondrium</span></p>"
      },
      {
        "id": 64427,
        "text": "<p><span style=\"font-size:12.0pt;\">During palpation, over the epigastrium</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 6-week-old infant is brought to the clinic with a history of projectile vomiting and poor weight gain. Physical examination reveals an abdominal mass in the epigastrium, and the diagnosis of congenital hypertrophic pyloric stenosis is suspected. An abdominal mass in a patient with congenital hypertrophic pyloric stenosis is best seen?&nbsp;</span>(NEET PG 2018)</p>",
    "unique_key": "Q4281652",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877388,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. During feeding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Congenital hypertrophic pyloric stenosis (CHPS)</strong> is a condition where the pylorus becomes hypertrophied and thickened. This leads to gastric outlet obstruction and symptoms such as projectile vomiting, dehydration, and electrolyte imbalances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">True. During feeding, or immediately after, the thickened muscle of the pylorus might be most palpable. As the stomach tries to empty its contents through the narrowed pylorus, the hypertrophied muscle can contract and become more prominent. This is called the \"olive-like mass\" which is palpable in the epigastrium to the right of the midline. This sign is pathognomonic for CHPS. The act of feeding induces peristaltic waves in the stomach, making the pyloric mass more prominent and easier to palpate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>B</strong>. <strong>Soon after birth</strong>: CHPS typically presents in the third to fifth week of life, although it can be present at birth. It is rare to palpate the mass immediately after birth. The symptoms usually progress, and the hypertrophic pylorus becomes more palpable as the condition worsens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>C</strong>. <strong>During palpation, over the left hypochondrium</strong>: The pylorus is located on the right side of the abdomen, so palpating the left hypochondrium wouldn't help in detecting a mass related to CHPS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>D</strong>. <strong>During palpation, over the epigastrium</strong>: While the hypertrophied pyloric muscle can indeed be felt in the epigastrium, its palpability becomes much more distinct during or after feeding due to the reasons mentioned in option A. The epigastrium is the upper central region of the abdomen and is the location where the \"olive-like mass\" of CHPS is most frequently palpated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In congenital hypertrophic pyloric stenosis, the characteristic \"olive-like mass\" is most easily palpated during or immediately after feeding when the stomach contracts against the hypertrophied pyloric muscle.</span></p>",
    "correct_choice_id": 64424,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13605,
    "choices": [
      {
        "id": 54381,
        "text": "<p><span style=\"font-size:12pt;\">Encephalopathy, AST, albumin, bilirubin, Prothrombin time</span></p>"
      },
      {
        "id": 54382,
        "text": "<p><span style=\"font-size:12pt;\">Encephalopathy, ascites, albumin, bilirubin, prothrombin time</span></p>"
      },
      {
        "id": 54383,
        "text": "<p><span style=\"font-size:12pt;\">Encephalopathy, AST, INR, albumin, bilirubin</span></p>"
      },
      {
        "id": 54384,
        "text": "<p><span style=\"font-size:12pt;\">Encephalopathy, ascites, albumin, bilirubin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of these are the components of Child Pugh score? (FMGE JANUARY 2023)</span></p>",
    "unique_key": "Q5323378",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877365,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Encephalopathy, ascites, albumin, bilirubin, prothrombin time.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Encephalitis, ascites, albumin, bilirubin, Prothrombin time are the components of Child Pugh score</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The Child-Pugh score is used to assess the prognosis of chronic liver disease and cirrhosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/untitled-103.jpg\" alt=\"\" width=\"1000\" height=\"512\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The components of the Child-Pugh score include encephalopathy, ascites, bilirubin, albumin, and prothrombin time (INR). This scoring system is used to assess the prognosis of chronic liver disease and cirrhosis.</span></p>",
    "correct_choice_id": 54382,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 34038,
    "choices": [
      {
        "id": 135987,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45X0</span></span></span></span></p>"
      },
      {
        "id": 135988,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">47XXY</span></span></span></span></p>"
      },
      {
        "id": 135989,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46X0</span></span></span></span></p>"
      },
      {
        "id": 135990,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">48XY</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The condition shown in the picture below is associated with which chromosomal abnormality? (FMGE JAN 2024)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/29/picture8_MKxcmMx.jpg\" style=\"height:269px; width:200px\" /></span></span></p>",
    "unique_key": "Q7084946",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877382,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 45XO</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image depicts a young female with features characteristic of Turner syndrome, which is associated with the chromosomal abnormality 45X0. Turner syndrome is characterized by a complete or partial absence of one of the X chromosomes. Key clinical features include short stature, webbed neck, widely spaced nipples, and delayed puberty. These physical findings align with the typical presentation of Turner syndrome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 47XXY (Klinefelter syndrome)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Klinefelter syndrome occurs in males and is characterized by the presence of an extra X chromosome (47XXY). This condition typically presents with tall stature, gynecomastia, and infertility, which do not match the features seen in the image.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 46X0 (XO mosaic)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option describes a mosaic form of Turner syndrome where some cells have a single X chromosome (45X0) while others have a typical female karyotype (46XX). While this is possible, the features described are more characteristic of classical Turner syndrome (45X0).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 48XY (Androgen Insensitivity Syndrome - AIS)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: AIS occurs in individuals with a male karyotype (46XY) but with insensitivity to androgens, resulting in incomplete or complete female external genitalia. However, AIS does not typically present with short stature, webbed neck, or widely spaced nipples, which are key features of Turner syndrome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Turner syndrome (45X0) presents with short stature, webbed neck, widely spaced nipples, and delayed puberty. Recognizing these phenotypic patterns is crucial for diagnosing and managing patients with developmental and reproductive disorders.</span></span></span></span></p>",
    "correct_choice_id": 135987,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14916,
    "choices": [
      {
        "id": 59624,
        "text": "<p><span style=\"font-size:12.0pt;\">High</span></p>"
      },
      {
        "id": 59625,
        "text": "<p><span style=\"font-size:12.0pt;\">Low</span></p>"
      },
      {
        "id": 59626,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal</span></p>"
      },
      {
        "id": 59627,
        "text": "<p><span style=\"font-size:12.0pt;\">Variable</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In osteoporosis, serum calcium and alkaline phosphatase levels are usually:(INICET MAY 2021)</span></p>",
    "unique_key": "Q2085536",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877394,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Normal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>OSTEOPOROSIS (V &gt; H &gt; C)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Osteoporosis is <strong>reduction in bone mass (density)</strong> i.e., there is <strong>quantitative decrease of units of bone formation</strong> but each unit has qualitatively normal configuration.</span></li><li><span style=\"font-size:12.0pt;\">Bone mineral density is measured by DEXA scan (65 years onwards)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Normal Ca<sup>2+</sup>, PO<sup>\u2011</sup><sub>4</sub>, ALP</strong></span></li><li><span style=\"font-size:12.0pt;\">Hemiplegic \u2013 Humerus maximum loss of bone mineral density</span></li></ul><p>&nbsp;</p><p><span style=\"color:#231f20;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_99_KW8BqA2.jpg\" alt=\"\" width=\"700\" height=\"280\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Radiological Investigation:</strong></span><span style=\"font-size:11pt;\">&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Quantitative CT is a newer imaging technique that can be used to detect osteoporosis</span></li><li><span style=\"font-size:12.0pt;\">Radiological features are <strong>loss of vertical height of vertebrae</strong> (collapse) and <strong>codfish appearance </strong>(concave superior and inferior surfaces) of vertebrae.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"color:#231f20;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/08/io52.jpg\" alt=\"\" width=\"238\" height=\"305\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Codfish vertebrae</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Estrogen</span></li><li><span style=\"font-size:12.0pt;\">Bisphosphonates \u2013 Increases hip fracture</span></li><li><span style=\"font-size:12.0pt;\">Calcitonin</span></li><li><span style=\"font-size:12.0pt;\">Low dose PTH \u2013 Stimulates osteoblasts</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In osteoporosis, the serum calcium and alkaline phosphatase levels remains normal. The bone density is decreased on the DEXA scan.</span></li></ul>",
    "correct_choice_id": 59626,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44299,
    "choices": [
      {
        "id": 176847,
        "text": "<p><span style=\"font-size:12.0pt;\">Ban smoking in public areas</span></p>"
      },
      {
        "id": 176848,
        "text": "<p><span style=\"font-size:12.0pt;\">Restrictions on alcohol selling/consumption</span></p>"
      },
      {
        "id": 176849,
        "text": "<p><span style=\"font-size:12.0pt;\">Shift from PUFA to trans-fat</span></p>"
      },
      {
        "id": 176850,
        "text": "<p><span style=\"font-size:12.0pt;\">Decrease additive salt on food</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What significant error did the intern make while creating a banner on measures to prevent the spread of non-communicable diseases, as assigned by a group of doctors?&nbsp; (</span>FMGE Jan 2024)</p>",
    "unique_key": "Q9959019",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877373,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Shift from PUFA to trans-fat</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The significant error made by the intern while creating the banner on measures to prevent the spread of non-communicable diseases was the recommendation to \"Shift from PUFA to trans-fat.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The other options, such as banning smoking in public areas, restricting alcohol selling/consumption, and decreasing additive salt on food, are appropriate measures to prevent non-communicable diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">However, the shifting from polyunsaturated fatty acids (PUFA) to trans-fats is incorrect, as trans-fats are one of the important risk factors for the development of non-communicable diseases. The recommendation should be to reduce trans-fat intake and promote the consumption of healthier fats like PUFA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>A. Ban smoking in public areas</strong> - This option is correct and should be included in the banner, as smoking is a major risk factor for non-communicable diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>B. Restrictions on alcohol selling/consumption</strong> - This option is correct and should be included in the banner, as alcohol consumption is a risk factor for conditions like coronary heart disease and hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>D. Decrease additive salt on food -</strong> This option is correct and should be included in the banner, as even prudent diet (a diet for dietary goal achievement) says the salt intake should be &lt;5gm/day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The significant error made by the intern was recommending a shift from polyunsaturated fatty acids (PUFA) to trans-fats, as trans-fats are known to increase the risk of non-communicable diseases, contrary to the goal of preventing their spread.</span></p>",
    "correct_choice_id": 176849,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10304,
    "choices": [
      {
        "id": 41182,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immunohistology</span></span></span></p>"
      },
      {
        "id": 41183,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Size</span></span></span></p>"
      },
      {
        "id": 41184,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cytogenetics</span></span></span></p>"
      },
      {
        "id": 41185,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Part of kidney involved</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most important determinant of malignant potential in the papillary type of renal tumor? (NEET PG 2018)</span></span></p>",
    "unique_key": "Q2528602",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877384,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Size </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The size of the tumor is the most important determinant of malignant potential in papillary renal tumors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Renal tumors of the papillary type include:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary adenoma of the kidney (&lt;/= 1.5 cm)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary renal cell carcinoma (RCC) - greater than 1.5 cm</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small renal papillary growths are fairly common and are discovered by chance. One of the processes carried out during the evaluation of donor transplant kidneys is the ruling out of malignancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Immunohistology:</span></strong><span style=\"font-size:12.0pt\"> While useful for diagnostic and subtyping purposes, it is not the primary determinant of malignant potential. It helps identify the type of cells involved and the presence of specific markers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cytogenetics:</span></strong><span style=\"font-size:12.0pt\"> Provides information on genetic abnormalities and can predict aggressiveness but is secondary to size in determining malignant potential.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Part of kidney involved:</span></strong><span style=\"font-size:12.0pt\"> Although the location can affect treatment approaches and outcomes, it does not primarily determine whether a tumor is malignant; size is more predictive of malignancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In papillary renal tumors, the size greater than 1.5 cm is the most critical determinant in assessing malignancy, outweighing factors like immunohistology, cytogenetics, and part of the kidney involved in terms of initial evaluation.</span></span></span></p>",
    "correct_choice_id": 41183,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44315,
    "choices": [
      {
        "id": 176911,
        "text": "<p><span style=\"font-size:12.0pt;\">Every Day</span></p>"
      },
      {
        "id": 176912,
        "text": "<p><span style=\"font-size:12.0pt;\">Every week</span></p>"
      },
      {
        "id": 176913,
        "text": "<p><span style=\"font-size:12.0pt;\">Every 14 days</span></p>"
      },
      {
        "id": 176914,
        "text": "<p><span style=\"font-size:12.0pt;\">Every Month</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Rukmani is attending a Village Nutrition and Sanitation Programme. How frequently is it conducted? (</span>FMGE Jan 2024)</p>",
    "unique_key": "Q1150536",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877378,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Every month</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Village Health Sanitation and Nutrition Committee organizes a Village Health Sanitation and Nutrition Day once every month.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rukmani is attending a \"Village Nutrition and Sanitation Programme,\" which is likely referring to the Village Health Sanitation and Nutrition Day organized by the committee.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Village Health Sanitation and Nutrition Programme, which Rukmani is attending, is conducted once every month by the Village Health Sanitation and Nutrition Committee.</span></p>",
    "correct_choice_id": 176914,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 23241,
    "choices": [
      {
        "id": 92928,
        "text": "<p><span style=\"font-size:12.0pt;\">Hinderer\u2019s lines</span></p>"
      },
      {
        "id": 92929,
        "text": "<p><span style=\"font-size:12.0pt;\">Marionettes line</span></p>"
      },
      {
        "id": 92930,
        "text": "<p><span style=\"font-size:12.0pt;\">Relaxed skin tension lines</span></p>"
      },
      {
        "id": 92931,
        "text": "<p><span style=\"font-size:12.0pt;\">Blaschko lines</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the following lines:&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/whatsapp-image-2023-06-12-at-190121011010201026_page_57.jpg\" alt=\"\" width=\"300\" height=\"313\"></span></p>",
    "unique_key": "Q6168274",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877386,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Blaschko lines</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Blaschko lines, also known as <strong>Blaschko's lines</strong>, are an intricate and unique pattern of skin markings that follow a specific distribution on the human body. They are not visible under normal circumstances and only become apparent when certain skin conditions or <strong>genetic&nbsp;</strong>disorders manifest. They are thought to represent the <strong>migration and proliferation&nbsp;</strong>of <strong>embryonic cells&nbsp;</strong>during early <strong>development</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hinderer\u2019s lines</strong> - Two intersecting lines, one from the ala to the tragus and one from the lateral canthus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/whatsapp-image-2023-06-12-at-190121011010201026_page_58.jpg\" alt=\"\" width=\"400\" height=\"407\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Marionette lines</strong> are&nbsp;wrinkles at the <strong>corners of mouth</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/whatsapp-image-2023-06-12-at-190121011010201026_page_59_ZMoJiTh.jpg\" alt=\"\" width=\"400\" height=\"221\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Relaxed skin tension</strong> lines refer to furrows that are&nbsp;created when the skin is pinched and relaxed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Blaschko lines offer a fascinating insight into human embryonic development and their pattern can help diagnose several dermatological conditions. Each of these lines has specific implications in medical practice, particularly in dermatology, plastic surgery, and cosmetic procedures, illustrating the intersection of clinical knowledge with aesthetic considerations.</span></p>",
    "correct_choice_id": 92931,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4104,
    "choices": [
      {
        "id": 16395,
        "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-2, C-4, D-1</span></p>"
      },
      {
        "id": 16396,
        "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-1,C-4 ,D-3</span></p>"
      },
      {
        "id": 16397,
        "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4</span></p>"
      },
      {
        "id": 16398,
        "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-3, C-1, D-2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the following parasites with their respective hosts: (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-161105.png\" alt=\"\" width=\"700\" height=\"228\"></span></p>",
    "unique_key": "Q1043331",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877379,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;A-3, B-2, C-4, D-1</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Diphyllobothrium latum:</strong> Humans (definitive host), Cyclops (first intermediate host), and Fish (second intermediate host).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Paragonimus westermani:</strong> Humans (definitive host), Snail (first intermediate host), Crayfish and Crab (second intermediate host).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Brugia malayi:</strong> Humans (definitive host), Mansonia mosquito (intermediate host).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fasciola hepatica:</strong> Sheep and Humans (definitive hosts), Snail (first intermediate host), Aquatic vegetation (second intermediate host).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-28%20115612.png\" width=\"1271\" height=\"236\"></p>",
    "correct_choice_id": 16395,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10093,
    "choices": [
      {
        "id": 40338,
        "text": "<p><span style=\"font-size:12.0pt;\">Contact dermatitis due to henna</span></p>"
      },
      {
        "id": 40339,
        "text": "<p><span style=\"font-size:12.0pt;\">Dermatitis artefacta</span></p>"
      },
      {
        "id": 40340,
        "text": "<p><span style=\"font-size:12.0pt;\">Polymorphous light eruption</span></p>"
      },
      {
        "id": 40341,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitiligo</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A school going child had applied henna and comes to dermatology OPD with the following lesions What is the possible diagnosis? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture2.jpg\" alt=\"\" width=\"300\" height=\"328\"></span></p>",
    "unique_key": "Q9322202",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877383,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Dermatitis artefacta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image points towards a likely diagnosis of <strong>dermatitis Artefacta</strong>.</span></p><p>&nbsp;</p><ul><li><span style=\"color:#0f0f0f;font-size:12.0pt;\">Dermatitis artefacta is a <strong>psychodermatological disorder</strong> where lesions are <strong>self-inflicted</strong>, often due to <strong>psychological stress</strong> or disorders. The pattern of the lesions, which are well-circumscribed and may follow an <strong>accessible pattern</strong> that the child could reach, is suggestive of dermatitis artefacta.</span></li><li><span style=\"font-size:12.0pt;\">Dermatitis artefacta is a condition in which the patient <strong>deliberately</strong> produces skin lesions <strong>without any rational motive</strong>. This is a <strong>psychological ailment</strong> where the <strong>patient is fully aware of their actions.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diagnosis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Indicated by the <strong>symmetrical placement</strong> of lesions in <strong>accessible areas</strong> on the <strong>face, neck, chest</strong> etc. Additionally, the lesions may exhibit varying <strong>stages of healing</strong>, similar to an abrasion.</span></li><li><span style=\"font-size:12.0pt;\">These visible symptoms of dermatitis artefacta can be seen as a form of <strong>nonverbal communication</strong>, representing a <strong>\"cry for attention and help\"</strong> from a patient who is unable to express their needs through meaningful verbal communication.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Contact dermatitis&nbsp;due to henna:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#0f0f0f;font-size:12.0pt;\">Contact dermatitis from henna, often related to the <strong>chemical para-phenylenediamine (PPD),</strong> usually manifests as a diffuse, <strong>erythematous rash</strong> in areas where the henna was applied.</span></li><li><span style=\"color:#0f0f0f;font-size:12.0pt;\">If the reaction were due to henna, one would expect to see an <strong>affected scalp</strong> where the henna was applied.</span></li><li><span style=\"color:#0f0f0f;font-size:12.0pt;\">However, the presence of <strong>localized lesions</strong> on <strong>the cheek</strong> and the normal appearance of the <strong>scalp</strong> suggests that this is <strong>not a case of allergic contact dermatitis (ACD) caused by henna</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. </strong></span><span style=\"font-size:12.0pt;\"><strong>Polymorphic light eruption (PLE):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#0f0f0f;font-size:12.0pt;\">This is an abnormal <strong>reaction to</strong> <strong>sunlight it is not expected</strong> to have a direct <strong>correlation</strong> with the application <strong>of henna.</strong></span></li><li><span style=\"font-size:12.0pt;\">Lesions will be small, <strong>itchy papules or Papulo-vesicles</strong> on an erythematous background. They will also be <strong>monomorphic </strong>(unlike as the name suggests).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitiligo:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:square;\"><li><span style=\"color:#0f0f0f;font-size:12.0pt;\">Vitiligo is characterized by <strong>depigmentation</strong> of the skin and would not present with erythematous or inflamed lesions as shown in the image.</span></li><li><span style=\"color:#0f0f0f;font-size:12.0pt;\">It represents a <strong>loss of pigment</strong> and is <strong>not physically raised or inflamed.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In assessing skin lesions, it's important to consider the <strong>psychological aspect of dermatology.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Dermatitis artefacta&nbsp;</strong>should be suspected in lesions that are <strong>localized</strong>, <strong>well-circumscribed</strong>, and do <strong>not</strong> have a <strong>distribution pattern</strong> consistent with the history or other physical causes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref:</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Rooks\u2019 textbook of dermatology 9<sup>th</sup> edition 128.13</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Kaplan &amp; Saddocks concise textbook of clinical Psychiatry 11<sup>th</sup> edition page 435, 436</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Fitzpatrick\u2019s dermatology 9<sup>th</sup> edition 405</strong></span></p>",
    "correct_choice_id": 40339,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11571,
    "choices": [
      {
        "id": 46250,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2</span></span></span></p>"
      },
      {
        "id": 46251,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3</span></span></span></p>"
      },
      {
        "id": 46252,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
      },
      {
        "id": 46253,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acid-base imbalance is suspected in a patient. Which of the following would you use to determine it? (INICET MAY 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arterial pH</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venous pH</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venous pO2</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venous pCO2</span></span></span></li>\r\n</ol>",
    "unique_key": "Q5780678",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877363,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) 1, 2, 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arterial pH is the gold standard for acid-base analysis as it directly measures the hydrogen ion concentration in arterial blood, providing a precise assessment of the patient&#39;s acid-base status. Venous pH and venous pCO2 can also provide reliable information about the patient&rsquo;s acid-base status and are often used in clinical settings where arterial blood gas (ABG) analysis is not feasible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Arterial pH and 2. Venous pH</span></strong><span style=\"font-size:12.0pt\">:&nbsp; </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arterial pH: This is the most accurate method for assessing acid-base balance. </span><span style=\"font-size:12.0pt\">Arterial pH varies by only 0.03 to 0.05 from venous pH. To estimate arterial pH from venous pH, add 0.03 to 0.05.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venous pCO2: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To estimate arterial pCO2 (PaCO2) from venous pCO2, subtract 5 from venous pCO2.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Venous pH and venous pCO2 can be used in some situations to predict arterial values.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Venous pO2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is not useful for determining acid-base imbalance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arterial pH, venous pH, and venous pCO2 are used to determine acid-base imbalances.</span></span></span></p>",
    "correct_choice_id": 46252,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13070,
    "choices": [
      {
        "id": 52242,
        "text": "<p><span style=\"font-size:12.0pt;\">Left occipital lobe</span></p>"
      },
      {
        "id": 52243,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffRight occipital lobe</span></p>"
      },
      {
        "id": 52244,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffLeft geniculate body</span></p>"
      },
      {
        "id": 52245,
        "text": "<p><span style=\"font-size:12.0pt;\">Optic chiasma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the site of the lesion: (</span>INICET May 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture13_6zdy8Mg.jpg\" alt=\"\" width=\"500\" height=\"261\"></span></p>",
    "unique_key": "Q4042651",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877400,
    "difficulty_level": "intermediate",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Left occipital lobe</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The visual field defect is right homonymous hemianopia with macular-sparing.</span></li><li><span style=\"font-size:12.0pt;\">It is caused by lesions of the left occipital lobe, which is contralateral/crossing of fibers.</span></li><li><span style=\"font-size:12.0pt;\">Head injury is a common cause of such lesions.</span></li><li><span style=\"font-size:12.0pt;\">These lesions may be associated with visual hallucinations, denial of blindness (Anton syndrome), and the Riddoch phenomenon.</span></li><li><span style=\"font-size:12.0pt;\">These lesions are commonly due to occlusion of the posterior cerebral artery. The part of the occipital lobe representing the peripheral field vision is supplied by the posterior cerebral artery.</span></li><li><span style=\"font-size:12.0pt;\">The lesions generally spare the central vision/macular vision since the area at the tip of the calcarine cortex, representing the central macular vision, is supplied by a branch of the middle cerebral artery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Right Occipital Lobe:</strong> This would cause a left-sided homonymous hemianopia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Left Geniculate Body:</strong> Lesions here typically produce similar visual field defects as occipital lobe lesions but may have different associated clinical signs and symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Optic Chiasma:</strong> Lesions at the optic chiasm typically produce bitemporal hemianopia, which is not demonstrated in the visual field tests provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture135.jpg\" alt=\"\" width=\"600\" height=\"499\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A lesion in the left occipital lobe is the most likely cause of the right homonymous hemianopia with macular sparing shown in the visual field tests. This understanding is critical for accurately diagnosing the underlying condition, potentially a vascular event, and directing appropriate management and intervention strategies.</span></p>",
    "correct_choice_id": 52242,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11180,
    "choices": [
      {
        "id": 44686,
        "text": "<p><span style=\"font-size:18px;\">Case control study</span></p>"
      },
      {
        "id": 44687,
        "text": "<p><span style=\"font-size:18px;\">Cohort study</span></p>"
      },
      {
        "id": 44688,
        "text": "<p><span style=\"font-size:18px;\">Cross-sectional study</span></p>"
      },
      {
        "id": 44689,
        "text": "<p><span style=\"font-size:18px;\">Clinical trial</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Imagine being part of a team aiming to identify the link between a novel nutritional supplement and its potential effects on muscle growth. You're tasked with deciding the most appropriate study design to establish a cause-and-effect relationship. Among the given options, which study design would be the most effective for demonstrating a connection between cause and effect? </strong><i><strong>[INICET NOV 2021]</strong></i></span></p>",
    "unique_key": "Q1464857",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877390,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Cohort study</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Cohort study is the most effective study design for showcasing the connection between a cause and an effect. A cohort study is a type of analytical (observational) study used for \u2018hypothesis testing\u2019. It is known by several synonyms:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">Prospective study</span></li><li><span style=\"font-size:18px;\">Forward looking study</span></li><li><span style=\"font-size:18px;\">Cause to effect study</span></li><li><span style=\"font-size:18px;\">Exposure to outcome study</span></li><li><span style=\"font-size:18px;\">Risk factor to disease study</span></li><li><span style=\"font-size:18px;\">Incidence study</span></li><li><span style=\"font-size:18px;\">Follow up study</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Case-control study:&nbsp;</strong>Case Control Study cannot provide with incidences, so Relative Risk cannot be calculated; In a Case Control Study, we calculate \u2018an estimate of Relative Risk\u2019, known as \u2018Odds Ratio\u2019 (CROSS PRODUCT RATIO).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Cross sectional study:</strong> A cross-sectional study is based on the single examination of a cross-section of a population \u2018at one point of time\u2019, results of sample are then projected to whole population. It cannot establish causality as \u2018does not establish time sequence\u2019.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Clinical trials:</strong> Clinical trials evaluates new studies, drugs and treatment effects on human population.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Cohort studies are ideal for establishing cause-and-effect relationships by following exposures over time and observing outcomes.</span></li></ul>",
    "correct_choice_id": 44687,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10298,
    "choices": [
      {
        "id": 41158,
        "text": "<p><span style=\"font-size:12.0pt;\">IL 1</span></p>"
      },
      {
        "id": 41159,
        "text": "<p><span style=\"font-size:12.0pt;\">Prostaglandins</span></p>"
      },
      {
        "id": 41160,
        "text": "<p><span style=\"font-size:12.0pt;\">TNF</span></p>"
      },
      {
        "id": 41161,
        "text": "<p><span style=\"font-size:12.0pt;\">Histamine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Fever occurs during inflammation due to all except: (NEET PG 2018)</span></p>",
    "unique_key": "Q6645236",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877376,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Histamine&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histamine is involved in the mediation of inflammatory vascular events rather than fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fever is defined by an increase in body temperature of 1\u00b0 to 4\u00b0C. It is a prominent manifestation of the acute-phase response, particularly when associated with infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyrogens are substances that cause fever. They can be either exogenous or endogenous.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Endogenous progens include IL-1, TNF, and prostaglandins.</span></li><li><span style=\"font-size:12.0pt;\">Exogenous pyrogens are bacterial lipopolysaccharides that stimulate leukocytes to release endogenous progens (IL-1 and TNF)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cytokines increase the activity of cyclooxygenases, which convert arachidonic acid into prostaglandins. These prostaglandins are produced in the hypothalamic vascular and perivascular cells. They stimulate the production of neurotransmitters in the hypothalamus, which raises the temperature setpoint. This is especially true of PGE2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options A. IL-1, B. Prostaglandins&nbsp;</strong>and<strong> C. TNF:</strong> These are all endogenous pyrogens that directly contribute to the fever response by influencing the temperature regulation in the hypothalamus and stimulating the production of prostaglandins that raise the body\u2019s temperature setpoint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histamine is involved in mediating the local vascular effects of inflammation and not in the fever response, which is primarily driven by IL-1, TNF, and prostaglandins.</span></p>",
    "correct_choice_id": 41161,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 59339,
    "choices": [
      {
        "id": 236669,
        "text": "<p><span style=\"font-size:16px;\">Albumin</span></p>"
      },
      {
        "id": 236670,
        "text": "<p><span style=\"font-size:16px;\">Bilirubin</span></p>"
      },
      {
        "id": 236671,
        "text": "<p><span style=\"font-size:16px;\">Prothrombin Time</span></p>"
      },
      {
        "id": 236672,
        "text": "<p><span style=\"font-size:16px;\">Creatinine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not a component of Child-Pugh scoring? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q8474795",
    "question_audio": null,
    "question_video": null,
    "map_id": 19877375,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Creatinine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Child-Pugh scoring system is used to assess the prognosis of chronic liver disease, mainly cirrhosis. It involves five clinical measures of liver disease, including:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Albumin</span></li><li><span style=\"font-size:16px;\">Bilirubin</span></li><li><span style=\"font-size:16px;\">Prothrombin Time (INR)</span></li><li><span style=\"font-size:16px;\">Ascites</span></li><li><span style=\"font-size:16px;\">Hepatic Encephalopathy</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">Creatinine is not included in the Child-Pugh scoring system. Instead, it is a component of the MELD (Model for End-Stage Liver Disease) score. The MELD score includes three parameters: creatinine, bilirubin, and INR. If it's MELD sodium, then it includes creatinine, bilirubin, INR, and sodium.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Albumin:</strong> Albumin is a component of the Child-Pugh score. It helps assess the synthetic function of the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Bilirubin:</strong> Bilirubin is another component of the Child-Pugh score. It indicates the liver's ability to excrete bile.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Prothrombin Time (INR):</strong> Prothrombin Time, measured as INR, is included in the Child-Pugh score to evaluate the liver's ability to produce clotting factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The Child-Pugh scoring system does not include creatinine as a parameter. Instead<strong>, creatinine is a part of the MELD score.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Note</strong> - The MELD score uses three parameters: Creatinine; Bilirubin and INR (International Normalized Ratio), so k/a CBI score. MELD Sodium Score includes Creatinine; Bilirubin; INR and sodium</span></p>",
    "correct_choice_id": 236672,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00107 Mid Day Module (Mixed Bag-4)';
        const quizFilename = '00107-mid-day-module-mixed-bag-4-2baf534a.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>